 |
|
|
|
|
|||||
|
|||||||||
|
|||||||||
 |
 |
||||||||
|
|
|||||||||
 |
|||||||||
 |
|||||||||
Nan Ping Wang, M.D., Ph.D. |
Medical School: School of Medicine, Taipei Medical University (Taipei, Taiwan, R.O.C.) Medical Ph.D.: Molecular Pathology Program (University of California, San Diego, CA) Residency(s): Laboratory Medicine (University of Washington, Seattle, WA) Pathology (University of Washington, Seattle, WA) Fellowship(s): Immunohistochemistry (University of Washington, Seattle, WA) Surgical Pathology & Hematopathology (University of Washington, Seattle, WA) Molecular Medicine (Institute of Biotechnology, Center for Molecular Medicine, University of Texas, San Antonio, TX) Board Certification(s): Anatomic Pathology Clinical Pathology Additional Sub-Specialty Expertise: Bone/Soft Tissue/ Joints Pathology Breast Pathology Immunohistochemistry |
Commentary/Medical Interests:
Dr. Wang is Director of Immunohistochemistry at CellNetix, and is fellowship-trained and with more than ten years of experience in the field. His Ph.D. training provides expertise in molecular biology, which has proven essential in the diagnosis and prognosis of tumors. Dr. Wang is also specialized in breast pathology, working intimately with surgeons, radiologists, and oncologists at Swedish breast care centers to provide multi-disciplinary care of breast cancer patients. |
|||||||
|
|||||||||
|
|||||||||
